Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations
- PMID: 23218570
- PMCID: PMC3819990
- DOI: 10.1016/j.ijcard.2012.10.046
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations
Abstract
Background: Ischaemic heart disease (IHD) is the leading cause of death worldwide. The World Health Organisation (WHO) collects mortality data coded using the International Statistical Classification of Diseases (ICD) code.
Methods: We analysed IHD deaths world-wide between 1995 and 2009 and used the UN population database to calculate age-specific and directly and indirectly age-standardised IHD mortality rates by country and region.
Results: IHD is the single largest cause of death worldwide, causing 7,249,000 deaths in 2008, 12.7% of total global mortality. There is more than 20-fold variation in IHD mortality rates between countries. Highest IHD mortality rates are in Eastern Europe and Central Asian countries; lowest rates in high income countries. For the working-age population, IHD mortality rates are markedly higher in low-and-middle income countries than in high income countries. Over the last 25 years, age-standardised IHD mortality has fallen by more than half in high income countries, but the trend is flat or increasing in some low-and-middle income countries. Low-and-middle income countries now account for more than 80% of global IHD deaths.
Conclusions: The global burden of IHD deaths has shifted to low-and-middle income countries as lifestyles approach those of high income countries. In high income countries, population ageing maintains IHD as the leading cause of death. Nevertheless, the progressive decline in age-standardised IHD mortality in high income countries shows that increasing IHD mortality is not inevitable. The 20-fold mortality difference between countries, and the temporal trends, may hold vital clues for handling IHD epidemic which is migratory, and still burgeoning.
Keywords: Coronary heart disease; Ischaemic heart disease; Mortality; Trends.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Figures





Similar articles
-
2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations.Int J Cardiol. 2014 Jun 15;174(2):293-8. doi: 10.1016/j.ijcard.2014.04.096. Epub 2014 Apr 13. Int J Cardiol. 2014. PMID: 24794549 Free PMC article.
-
Mortality From Ischemic Heart Disease.Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375. Epub 2019 Jun 4. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31163980 Free PMC article.
-
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582094 Free PMC article.
-
The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data.Int J Cardiol. 2016 Dec 1;224:256-264. doi: 10.1016/j.ijcard.2016.09.026. Epub 2016 Sep 15. Int J Cardiol. 2016. PMID: 27664572 Review.
-
Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.Lancet Glob Health. 2013 Nov;1(5):e259-81. doi: 10.1016/S2214-109X(13)70089-5. Epub 2013 Oct 24. Lancet Glob Health. 2013. PMID: 25104492 Free PMC article. Review.
Cited by
-
CLEC3B protects H9c2 cardiomyocytes from apoptosis caused by hypoxia via the PI3K/Akt pathway.Braz J Med Biol Res. 2020;53(9):e9693. doi: 10.1590/1414-431x20209693. Epub 2020 Jul 17. Braz J Med Biol Res. 2020. PMID: 32696821 Free PMC article.
-
Weighted gene co-expression network analysis to identify key modules and hub genes related to hyperlipidaemia.Nutr Metab (Lond). 2021 Mar 4;18(1):24. doi: 10.1186/s12986-021-00555-2. Nutr Metab (Lond). 2021. PMID: 33663541 Free PMC article.
-
An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.Drug Des Devel Ther. 2014 Dec 17;9:33-78. doi: 10.2147/DDDT.S72892. eCollection 2015. Drug Des Devel Ther. 2014. PMID: 25552899 Free PMC article. Review.
-
Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial.Front Cardiovasc Med. 2022 Oct 21;9:1002400. doi: 10.3389/fcvm.2022.1002400. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36386372 Free PMC article.
-
Targeted temperature management in cardiovascular disease complicated by cardiac arrest.Ir J Med Sci. 2017 Feb;186(1):123-127. doi: 10.1007/s11845-016-1461-3. Epub 2016 May 4. Ir J Med Sci. 2017. PMID: 27147219
References
-
- Xu J.Q., Kochanek K.D., Murphy S.L., Tejada-Vera B. vol. 58 no. 19. National Center for Health Statistics; Hyattsville, MD: 2010. Deaths: final data for 2007. (National vital statistics reports). - PubMed
-
- Scarborough P., Wickramasinghe K., Bhatnagar P., Rayner M. British Heart Foundation; London: 2011. Trends in coronary heart disease 1961–2011.
-
- Rosamond W., Flegal K., Furie K. Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25–e146. - PubMed
-
- Scarborough P., Bhatnagar P., Wickramasinghe K., Smolina K., Mitchell C., Rayner M. British Heart Foundation; 2010. Coronary heart disease statistics.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical